|
TMEM181 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.217500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.580700E-03 |
| Normal-vs-Stage2 |
3.669900E-02 |
| Normal-vs-Stage3 |
6.393300E-04 |
| Normal-vs-Stage4 |
2.427700E-04 |
| Stage1-vs-Stage2 |
7.459400E-01 |
| Stage1-vs-Stage3 |
4.785900E-02 |
| Stage1-vs-Stage4 |
1.467680E-02 |
| Stage2-vs-Stage3 |
1.255450E-01 |
| Stage2-vs-Stage4 |
5.171800E-02 |
| Stage3-vs-Stage4 |
4.685200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.475810E-03 |
| Normal-vs-AfricanAmerican |
8.400400E-02 |
| Normal-vs-Asian |
1.804510E-03 |
| Caucasian-vs-AfricanAmerican |
3.006200E-01 |
| Caucasian-vs-Asian |
7.657400E-01 |
| AfricanAmerican-vs-Asian |
3.023400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.226300E-04 |
| Normal-vs-Female |
9.115200E-03 |
| Male-vs-Female |
2.215200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.935500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.679100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.485510E-02 |
| Normal-vs-Age(81-100Yrs) |
3.706300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.239400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.823400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.767800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.230600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.981400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.611200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.592000E-01 |
| Classical-VS-Follicular |
2.736200E-02 |
| Classical-VS-Other |
1.226180E-01 |
| Classical-VS-Normal |
2.282100E-03 |
| Tall-VS-Follicular |
2.264400E-02 |
| Tall-VS-Other |
8.589800E-02 |
| Tall-VS-Normal |
1.878230E-03 |
| Follicular-VS-Other |
1.920200E-03 |
| Follicular-VS-Normal |
2.098800E-01 |
| Other-VS-Normal |
1.812810E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.678100E-03 |
| Normal-vs-N1 |
1.414580E-04 |
| N0-vs-N1 |
1.011870E-02 |
|
|
